Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The first 6 months of HIV-SARS-CoV-2 coinfection: outcomes for 6947 individuals

The first 6 months of HIV-SARS-CoV-2 coinfection: outcomes for 6947 individuals Purpose of reviewThe aim of this review is to summarize the clinical outcomes of people living with HIV (PWH) coinfected with SARS-CoV-2 during the first six months of the COVID-19 pandemic.Recent findingsSeveral reports from single centers have described increased, decreased, or no difference in outcomes of COVID-19 in PWH. These studies have come from a range of locations, each with different underlying HIV prevalence and access to various antiretroviral therapy (ART) regimens. Differences in healthcare quality, access and policies may also affect reported outcomes in PWH across different locations, making interpretation of results more challenging. Meanwhile, different components of ART have been proposed to protect against SARS-CoV-2 acquisition or disease progression.SummaryThe current review considers 6 months of data across geographic regions with a range of healthcare quality and access and ART regimens to generate a wider view of COVID-19 outcomes in PWH. Taken together, these studies indicate that HIV infection may be associated with increased risk of COVID-19 diagnosis, but comorbidities appear to play a larger role than HIV-specific variables in outcomes of COVID-19 among PWH. ART does not appear to protect from COVID-19 disease acquisition, progression or death. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Opinion in HIV & AIDS Wolters Kluwer Health

The first 6 months of HIV-SARS-CoV-2 coinfection: outcomes for 6947 individuals

Johnston, Rowena
Current Opinion in HIV & AIDS , Volume 16 (1) – Jan 5, 2021
Download PDF
9 pages

Loading next page...
 
/lp/wolters-kluwer-health/the-first-6-months-of-hiv-sars-cov-2-coinfection-outcomes-for-6947-70rOb07qXD

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Wolters Kluwer Health
Copyright
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
ISSN
1746-630X
eISSN
1746-6318
DOI
10.1097/COH.0000000000000654
Publisher site
See Article on Publisher Site

Abstract

Purpose of reviewThe aim of this review is to summarize the clinical outcomes of people living with HIV (PWH) coinfected with SARS-CoV-2 during the first six months of the COVID-19 pandemic.Recent findingsSeveral reports from single centers have described increased, decreased, or no difference in outcomes of COVID-19 in PWH. These studies have come from a range of locations, each with different underlying HIV prevalence and access to various antiretroviral therapy (ART) regimens. Differences in healthcare quality, access and policies may also affect reported outcomes in PWH across different locations, making interpretation of results more challenging. Meanwhile, different components of ART have been proposed to protect against SARS-CoV-2 acquisition or disease progression.SummaryThe current review considers 6 months of data across geographic regions with a range of healthcare quality and access and ART regimens to generate a wider view of COVID-19 outcomes in PWH. Taken together, these studies indicate that HIV infection may be associated with increased risk of COVID-19 diagnosis, but comorbidities appear to play a larger role than HIV-specific variables in outcomes of COVID-19 among PWH. ART does not appear to protect from COVID-19 disease acquisition, progression or death.

Journal

Current Opinion in HIV & AIDS – Wolters Kluwer Health

Published: Jan 5, 2021

References

  • The virus that changed Spain: impact of COVID-19 on people with HIV
  • [Withdrawn] Guidance on social distancing for everyone in the UK 2020
  • Coronavirus disease 2019 (COVID-19) people with certain medical conditions 2020
  • COVID-19: avoiding a second tragedy in a tuberculosis burdened country
  • Frequency of noncommunicable diseases in people 50 years of age and older receiving HIV care in Latin America
  • Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy
  • HIV infection in hard-to-reach populations
  • Concomitant socioeconomic, behavioral, and biological factors associated with the disproportionate HIV infection burden among Black men who have sex with men in 6 U.S. cities
  • Hispanics/Latinos and the HIV continuum of care in the Southern USA: a qualitative review of the literature, 2002–2013
  • Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area
  • OpenSAFELY: factors associated with COVID-19 death in 17 million patients
  • Comorbidity indices in people with HIV and considerations for coronavirus disease 2019 outcomes
  • Multimorbidity among persons living with human immunodeficiency virus in the United States
  • Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
  • Central memory CD4+ T cell responses in chronic HIV infection are not restored by antiretroviral therapy
  • Long-term immune responses to vaccination in HIV-infected patients: a systematic review and meta-analysis
  • Dendritic cells from HIV-1 infected individuals are less responsive to toll-like receptor (TLR) ligands
  • Immune checkpoint blockade restores HIV-specific CD4 T cell help for NK cells
  • Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals
  • Loss of preexisting immunological memory among human immunodeficiency virus-infected women despite immune reconstitution with antiretroviral therapy
  • Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study
  • HIV, tuberculosis, and malaria: how can the impact of COVID-19 be minimised?
  • Predicting commercially available antiviral drugs that may act on the novel coronavirus (2019-nCoV), Wuhan, China through a drug-target interaction deep learning model
  • Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID-19: initial assessment
  • The potential of drug repositioning as a short-term strategy for the control and treatment of COVID-19 (SARS-CoV-2): a systematic review
  • Why aren’t people living with HIV at higher risk for developing severe coronavirus disease 2019 (COVID-19)?
  • Male gender and kidney illness associated with an increased risk of severe laboratory-confirmed coronavirus disease
  • Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series
  • Characteristics associated with hospitalization among patients with COVID-19 – Metropolitan Atlanta, Georgia, March–April 2020
  • Risk factors for mortality in patients with COVID-19 in New York City
  • Cardiovascular comorbidities, cardiac injury, and prognosis of COVID-19 in New York City
  • COVID-19 attack rate in HIV-infected patients and in PrEP users
  • A model of disparities: clinical, environmental, and sociodemographic risk factors associated with likelihood of COVID-19 contraction
  • Comparison of multimorbidity in COVID-19 infected and general population in Portugal
  • Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infection
  • Evidence of gender bias in the diagnosis and management of COVID-19 patients: a Big Data analysis of Electronic Health Records
  • Clinical, behavioral and social factors associated with racial disparities in hospitalized and ambulatory COVID-19 patients from an integrated healthcare system in Georgia
  • Effect of underlying comorbidities on the infection and severity of COVID-19 in Korea: a nationwide case–control study
  • HIV and risk of COVID-19 death: a population cohort study from the Western Cape Province, South Africa
  • Descriptive epidemiology of 16,780 hospitalized COVID-19 patients in the United States
  • Development and validation of a clinical risk score to predict the risk of SARS-CoV-2 infection from administrative data: a population-based cohort study from Italy
  • Prior diagnoses and medications as risk factors for COVID-19 in a Los Angeles Health System
  • Clinical utility of targeted SARS-CoV-2 serology testing to aid the diagnosis and management of suspected missed, late or post-COVID-19 infection syndromes: results from a pilot service
  • Profiling presymptomatic and asymptomatic cases with confirmed SARS-CoV-2 infection in Mexico City
  • Ending the HIV epidemic database
  • HIV and AIDS in South Africa
  • The World Factbook, Portugal
  • Epidemiological characteristics of HIV infected Korean: Korea HIV/AIDS Cohort Study
  • Population and geography: New York City (NYC) age and sex distribution – by county
  • Vigilancia Epidemiológica del VIHy sida en España2018: Sistema de Información sobre Nuevos Diagnósticos de VIH y Registro Nacional de Casos de Sida
  • New York State HIV/AIDS Annual Surveillance Report for persons diagnosed through December 2018
  • Institut national de la statistique et des études économiques 2019
  • Country demographics
  • Population statistics for countries, administrative divisions, cities, urban areas and agglomerations
  • Aggiornamento Delle Nuove Diagnosi di Infezione Da Hiv E Dei Casi Di Aids In Italiaal 31 Dicembre 2018
  • Respuesta al VIH, Sida e ITS 2013–2018
  • Population of London in the United Kingdom (UK) in 2019, by age group (in 1,000 s) 2019
  • Alcohol use, expectancies, and sexual sensation seeking as correlates of HIV risk behavior in heterosexual young adults
  • Decision making and personality factors in sexual risk-taking for HIV/AIDS: a theoretical integration
  • Coronavirus disease 2019 in an orthotopic liver transplant recipient living with human immunodeficiency virus
  • Clinical characteristics, outcomes and prognosticators in adult patients hospitalized with COVID-19
  • Predictors of mortality in adults admitted with COVID-19: retrospective cohort study from New York City
  • Analysis of hospitalized COVID-19 patients in the Mount Sinai Health System using electronic medical records (EMR) reveals important prognostic factors for improved clinical outcomes
  • A cohort of patients with COVID-19 in a major teaching hospital in Europe
  • High in-hospital mortality due to COVID-19 in a community hospital in Spain: a prospective observational study
  • Patient trajectories and risk factors for severe outcomes among persons hospitalized for COVID-19 in the Maryland/DC region
  • Vital signs assessed in initial clinical encounters predict COVID-19 mortality in an NYC hospital system
  • The association between biomarkers and clinical outcomes in novel coronavirus (COVID-19) pneumonia in a U.S. cohort
  • Cases of coronavirus disease-2019 in HIV-infected transgender women
  • HIV and SARS-CoV-2 coinfection: a case report from Uganda
  • Four cases: human immunodeficiency virus and novel coronavirus 2019 co-infection in patients from Long Island, New York
  • COVID-19 in patients with HIV: clinical case series
  • SARS-CoV-2 and HIV coinfection: clinical experience from Rhode Island, United States
  • Computed tomography imaging of an HIV-infected patient with coronavirus disease
  • Coronavirus disease 2019 and Pneumocystis jirovecii pneumonia: a diagnostic dilemma in HIV
  • SARS-CoV-2 infection in a highly experienced person living with HIV
  • Clinical features and outcomes of HIV patients with coronavirus disease
  • Patterns of HIV and SARS-CoV-2 co-infection in Wuhan, China
  • Encephalopathy and seizure activity in a COVID-19 well controlled HIV patient
  • COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients
  • Severe SARS-CoV-2 pneumonia in a 58-year-old patient with HIV: a clinical case report from the Republic of Cyprus
  • COVID-19 in an HIV-positive kidney transplant recipient
  • The characteristics of two patients coinfected with SARS-CoV-2 and HIV in Wuhan, China
  • Report of a COVID-19 case combined with HIV infection
  • Pneumocystis Jirovecii pneumonia and SARS-CoV-2 co-infection in newly diagnosed HIV-1 infection
  • HIV and SARS CoV-2 co-infection: a retrospective, record based, case series from South India
  • Case report: one case of coronavirus disease 2019 (COVID-19) in a patient co-infected by HIV with a normal CD4(+) T cell count
  • Disproportionate burden of COVID-19 among racial minorities and those in congregate settings among a large cohort of people with HIV
  • Recovery from COVID-19 following hepatitis C, human immunodeficiency virus infection, and liver transplantation
  • A case of SARS-CoV-2 infection in an untreated HIV patient in Tokyo, Japan
  • COVID-19 in a patient with HIV infection
  • COVID-19 crossing paths with AIDS in the homeless
  • Analysis of the consequences of the COVID-19 pandemic on the continuum of the care in a cohort of HIV-positive patients followed in a single center of Northern Italy
  • Successful management of the first case of SARS-CoV-2 infection in an Iranian HIV patient
  • A case series of five people living with HIV hospitalized with COVID-19 in Chicago, Illinois
  • Darunavir does not prevent SARS-CoV-2 infection in HIV patients
  • Thromboprophylaxis in a patient with COVID-19 and severe hemophilia A on emicizumab prophylaxis
  • Clinical features and outcomes of four HIV patients with COVID-19 in Wuhan, China
  • Secondary tension pneumothorax in a COVID-19 pneumonia patient: a case report
  • Infection of severe acute respiratory syndrome coronavirus 2 in a patient with AIDS
  • A case of HIV and SARS-CoV-2 co-infection in Singapore
  • Clinical features and outcome of HIV/SARS-CoV-2 coinfected patients in The Bronx, New York City
  • Variation in mortality of HIV/SARS-CoV-2 coinfected patients in the Bronx, New York City
  • COVID-19 in three people living with HIV in the United Kingdom
  • One case of coronavirus disease 2019 (COVID-19) in a patient co-infected by HIV with a low CD4(+) T-cell count
  • Outcomes of a rapid adolescent telehealth scale-up during the COVID-19 pandemic
  • Recovery from the coronavirus disease-2019 (COVID-19) in two patients with coexisted (HIV) infection
  • The reflection on an AIDS patient with asymptomatic COVID-19
  • Clinical characteristics and comparative analysis of Covid-19 patients with or without HIV coinfection in Wuhan
  • Early virus clearance and delayed antibody response in a case of COVID-19 with a history of co-infection with HIV-1 and HCV
  • Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China
  • Incidence and severity of COVID-19 in HIV-positive persons receiving antiretroviral therapy: a cohort study
  • Spanish study raises possibility that old-style tenofovir might protect against COVID-19
  • HIV raises the risk of death from COVID-19 in South Africa's Western Cape
  • Does taking HIV meds reduce the odds of COVID-19? Experts say, ‘not so fast’
  • Human development index
  • Policy lessons from early reactions to the COVID-19 virus in China
  • Clinical outcomes and immunologic characteristics of Covid-19 in people with HIV
  • Covid-19 and people with HIV infection: outcomes for hospitalized patients in New York City
  • Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort
  • Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 – United States, February 12–March 28, 2020
  • Considering how biological sex impacts immune responses and COVID-19 outcomes
  • Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study
  • Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys